Patricia J Godsen, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4451 Mahoning Ave Nw Ste A, Warren, OH 44483 Phone: 330-372-0207 |
Lesley Anne Bucey, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4329 Mahoning Ave Nw Ste B, Warren, OH 44483 Phone: 330-847-7819 Fax: 330-847-8192 |
Michael Kotyuk, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1932 Niles Cortland Rd Ne, Warren, OH 44484 Phone: 330-856-1520 Fax: 330-856-7342 |
Nicholas Alan Sanders, P.T. Physical Therapist - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 140 Highland Terrace Blvd, Warren, OH 44484 Phone: 330-652-8733 |
Danielle Maricia Lawrence, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2103 Niles Cortland Rd Se, Warren, OH 44484 Phone: 330-544-3737 Fax: 330-544-3904 |
Hans Werner Kirr, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1932 Niles Cortland Rd Ne, Warren, OH 44484 Phone: 330-856-1520 Fax: 330-856-7342 |
Athena Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 260 Niles Cortland Rd Ne, Warren, OH 44484 Phone: 330-609-5791 |
News Archive
BD, a leading global medical technology company, announced today that it has acquired Sirigen Group Limited, a developer of unique polymer dyes that are used in flow cytometry and can be applied to other technologies.
Dr. R. Clinton Webb, Herbert S. Kupperman Chair in Cardiovascular Disease in the Department of Physiology at the Medical College of Georgia at Augusta University, has been selected for the top award from the American Heart Association's Council on Hypertension.
An elaborate statistical analysis of genes from more than 7,000 individuals has identified an amino acid that appears to be a major risk factor for multiple sclerosis, a devastating autoimmune disorder that afflicts 2.5 million people worldwide.
A study conducted by a collaborative team led by researchers from the University of Southern California (USC) may lead to better insight into the clinical outcome for some patients with a particularly aggressive type of brain cancer. The research may also provide a framework for development of targeted drug treatments.
› Verified 4 days ago